Patrick Horne

4.9k total citations · 2 hit papers
21 papers, 3.2k citations indexed

About

Patrick Horne is a scholar working on Physiology, Molecular Biology and Neurology. According to data from OpenAlex, Patrick Horne has authored 21 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 6 papers in Molecular Biology and 6 papers in Neurology. Recurrent topics in Patrick Horne's work include Alzheimer's disease research and treatments (10 papers), Computational Drug Discovery Methods (5 papers) and Neurogenetic and Muscular Disorders Research (5 papers). Patrick Horne is often cited by papers focused on Alzheimer's disease research and treatments (10 papers), Computational Drug Discovery Methods (5 papers) and Neurogenetic and Muscular Disorders Research (5 papers). Patrick Horne collaborates with scholars based in Canada, United States and Belgium. Patrick Horne's co-authors include Peter St George‐Hyslop, M. Azhar Chishti, Howard T.J. Mount, Paul M. Mathews, Christopher Janus, David Westaway, JoAnne McLaurin, Paul E. Fraser, Stephen D. Schmidt and Ralph A. Nixon and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Patrick Horne

20 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

2000 1.2k citations Christopher Janus, Jacqueline Pearson et al. Nature profile →
Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress

2005 566 citations Raymond H. Kim, Patrice D. Smith et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick Horne Canada	15	1.8k	1.2k	829	825	634	21	3.2k
Dale B. Schenk United States	27	2.1k 1.2×	1.9k 1.6×	508 0.6×	310 0.4×	623 1.0×	36	3.8k
Jessie Theuns Belgium	30	1.8k 1.0×	1.5k 1.2×	1.1k 1.3×	463 0.6×	725 1.1×	53	3.2k
Sarah L. DeVos United States	22	2.6k 1.4×	1.6k 1.3×	714 0.9×	1.1k 1.4×	1.1k 1.8×	24	3.9k
Yungui Zhou United States	22	2.2k 1.2×	1.5k 1.2×	404 0.5×	1.3k 1.6×	706 1.1×	29	4.3k
Sylvain Lesné United States	27	2.0k 1.1×	1.2k 1.0×	288 0.3×	739 0.9×	848 1.3×	38	3.1k
Urmi Sengupta United States	33	3.3k 1.9×	1.9k 1.6×	990 1.2×	1.2k 1.5×	1.1k 1.8×	69	4.7k
Birgit Hutter‐Paier Austria	30	1.9k 1.0×	1.1k 0.9×	438 0.5×	975 1.2×	669 1.1×	106	3.4k
Robin Barbour United States	23	3.2k 1.8×	1.8k 1.5×	1.8k 2.2×	820 1.0×	1.2k 1.9×	35	5.0k
Bruno Vincent France	33	2.1k 1.2×	2.1k 1.7×	227 0.3×	614 0.7×	994 1.6×	70	4.2k
Tiziana Borsello Italy	31	1.5k 0.9×	2.1k 1.8×	272 0.3×	742 0.9×	1.2k 1.9×	82	4.1k

Countries citing papers authored by Patrick Horne

Since Specialization

Citations

This map shows the geographic impact of Patrick Horne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Horne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Horne more than expected).

Fields of papers citing papers by Patrick Horne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Horne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Horne. The network helps show where Patrick Horne may publish in the future.

Co-authorship network of co-authors of Patrick Horne

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Horne. A scholar is included among the top collaborators of Patrick Horne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Horne. Patrick Horne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Park, Haesuk, Carolyn Brown, Debbie L. Wilson, et al.. (2023). Clinician barriers, perceptions, and practices in treating patients with hepatitis C virus and substance use disorder in the United States. Preventive Medicine Reports. 32. 102138–102138. 3 indexed citations

Horne, Patrick, Roger M. Mills, C. Soldevila‐Pico, et al.. (2012). The anti‐viral effect of sorafenib in hepatitis C‐related hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics. 37(1). 91–97. 21 indexed citations

Hanna, Amanda, Patrick Horne, Debra Yager, et al.. (2009). Amyloid β and impairment in multiple memory systems in older transgenic APP TgCRND8 mice. Genes Brain & Behavior. 8(7). 676–684. 19 indexed citations

Liu, Hsueh‐Ning, Teresa Sanelli, Patrick Horne, et al.. (2009). Lack of evidence of monomer/misfolded superoxide dismutase‐1 in sporadic amyotrophic lateral sclerosis. Annals of Neurology. 66(1). 75–80. 69 indexed citations

Xiao, Shangxi, Teresa Sanelli, Jesse R. McLean, et al.. (2008). An Aggregate-Inducing Peripherin Isoform Generated through Intron Retention Is Upregulated in Amyotrophic Lateral Sclerosis and Associated with Disease Pathology. Journal of Neuroscience. 28(8). 1833–1840. 53 indexed citations

Watts, Joel C., Bettina Drisaldi, Jing Yang, et al.. (2007). The CNS glycoprotein Shadoo has PrPC-like protective properties and displays reduced levels in prion infections. The EMBO Journal. 26(17). 4038–4050. 113 indexed citations

Sanelli, Teresa, Shangxi Xiao, Patrick Horne, et al.. (2007). Evidence That TDP-43 is Not the Major Ubiquitinated Target Within the Pathological Inclusions of Amyotrophic Lateral Sclerosis. Journal of Neuropathology & Experimental Neurology. 66(12). 1147–1153. 40 indexed citations

Bai, Yu, Kelly A. Markham, Fusheng Chen, et al.. (2007). The in Vivo Brain Interactome of the Amyloid Precursor Protein. Molecular & Cellular Proteomics. 7(1). 15–34. 137 indexed citations

Robertson, Janice, Teresa Sanelli, Shangxi Xiao, et al.. (2007). Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS. Neuroscience Letters. 420(2). 128–132. 106 indexed citations

10.

Rakhit, Rishi, Janice Robertson, Christine Vande Velde, et al.. (2007). An immunological epitope selective for pathological monomer-misfolded SOD1 in ALS. Nature Medicine. 13(6). 754–759. 188 indexed citations

11.

Mastrangelo, Peter, Paul M. Mathews, M. Azhar Chishti, et al.. (2005). Dissociated phenotypes in presenilin transgenic mice define functionally distinct γ-secretases. Proceedings of the National Academy of Sciences. 102(25). 8972–8977. 64 indexed citations

12.

Kim, Raymond H., Patrice D. Smith, Hossein Aleyasin, et al.. (2005). Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proceedings of the National Academy of Sciences. 102(14). 5215–5220. 566 indexed citations breakdown →

13.

Phinney, Amie L., et al.. (2003). Mouse models of Alzheimer's disease: The long and filamentous road. Neurological Research. 25(6). 590–600. 35 indexed citations

14.

Hasegawa, Hiroshi, Christopher Janus, Jacqueline Pearson, et al.. (2003). Aβ vaccination of a genetic model of Alzheimer's disease. International Congress Series. 1252. 405–409. 1 indexed citations

15.

Phinney, Amie L., Bettina Drisaldi, Stephen D. Schmidt, et al.. (2003). In vivo reduction of amyloid-β by a mutant copper transporter. Proceedings of the National Academy of Sciences. 100(24). 14193–14198. 175 indexed citations

16.

McLaurin, JoAnne, Tian Xu, Amie L. Phinney, et al.. (2002). Therapeutically effective antibodies against amyloid-β peptide target amyloid-β residues 4–10 and inhibit cytotoxicity and fibrillogenesis. Nature Medicine. 8(11). 1263–1269. 359 indexed citations

17.

Westaway, David, Christopher Janus, M. Azhar Chishti, et al.. (2002). Aβ-immunization reduces learning impairment and amyloid plaque burden in an animal model of Alzheimer's disease. European Neuropsychopharmacology. 12. 98–98. 1 indexed citations

18.

Janus, Christopher, Jacqueline Pearson, JoAnne McLaurin, et al.. (2000). Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature. 408(6815). 979–982. 1183 indexed citations breakdown →

19.

Horne, Patrick & Robert R. Ireland. (1991). Moss and a Guanche Mummy: An Unusual Utilization. The Bryologist. 94(4). 407–407. 2 indexed citations

20.

Horne, Patrick & A. D. Forrest. (1962). Pilot Trial of I.C.I. 31397 a New Mono-Amine Oxidase Inhibitor. Scottish Medical Journal. 7(5). 224–229. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact